ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Louis W Sullivan. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Louis W Sullivan har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:UTHR / United Therapeutics Corporation Director 590
US:EBS / Emergent BioSolutions Inc. Director 139.098
US:HSIC / Henry Schein, Inc. Director 10.811
US:BPAX / Director 10.000
US:EFX / Equifax Inc. Director 7.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Louis W Sullivan. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ANIP / ANI Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ANIP / ANI Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ANIP / ANI Pharmaceuticals, Inc. Insider Trades
Insidersalg ANIP / ANI Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ANIP / ANI Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ANIP / ANI Pharmaceuticals, Inc. Insider Trades
Insiderkøb EBS / Emergent BioSolutions Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ANIP / ANI Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EBS / Emergent BioSolutions Inc. Insider Trades
Insidersalg EBS / Emergent BioSolutions Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ANIP / ANI Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2020-09-02 EBS SULLIVAN LOUIS W 20.525 111,2157 20.525 111,2157 2.282.702 265 56.61 -1.120.782 -49,10
2020-09-02 EBS SULLIVAN LOUIS W 7.893 111,2256 7.893 111,2256 877.904
2020-03-04 EBS SULLIVAN LOUIS W 7.893 58,9582 7.893 58,9582 465.357
2020-03-04 EBS SULLIVAN LOUIS W 7.893 58,9582 7.893 58,9582 465.357
2016-05-13 EBS SULLIVAN LOUIS W 4.131 39,0000 4.131 39,0000 161.109
2016-05-13 EBS SULLIVAN LOUIS W 21.600 39,1900 21.600 39,1900 846.504
2016-05-13 EBS SULLIVAN LOUIS W 21.600 39,2800 21.600 39,2800 848.448
2016-05-12 EBS SULLIVAN LOUIS W 300 39,0000 300 39,0000 11.700
2016-05-11 EBS SULLIVAN LOUIS W 9.969 39,2500 9.969 39,2500 391.283
2016-03-11 EBS SULLIVAN LOUIS W 14.879 34,0300 14.879 34,0300 506.332
2016-03-10 EBS SULLIVAN LOUIS W 14.820 35,3400 14.820 35,3400 523.739
2015-06-16 EBS SULLIVAN LOUIS W 13.457 31,3250 13.457 31,3250 421.541

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EBS / Emergent BioSolutions Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Louis W Sullivan som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-07-28 2025-07-25 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 590 590
2025-05-02 2025-04-30 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 34.403 139.098 32,86
2024-12-19 2024-12-19 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
G - Gift -1.851 3.200 -36,65
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -100 5.051 -1,94 382,24 -38.224 1.930.719
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -800 5.151 -13,44 381,37 -305.099 1.964.456
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -944 5.951 -13,69 379,67 -358.412 2.259.441
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -400 6.895 -5,48 377,46 -150.984 2.602.587
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2.700 7.295 -27,01 375,03 -1.012.581 2.735.844
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.962 9.995 -16,41 374,17 -734.115 3.739.796
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.525 11.957 -11,31 373,06 -568.914 4.460.659
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -100 13.482 -0,74 370,78 -37.078 4.998.856
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.926 13.582 -12,42 370,02 -712.649 5.025.546
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -752 15.508 -4,62 368,67 -277.238 5.717.306
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -100 16.260 -0,61 382,63 -38.263 6.221.564
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -620 16.360 -3,65 381,41 -236.475 6.239.876
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -700 16.980 -3,96 380,12 -266.084 6.454.438
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -200 17.680 -1,12 379,30 -75.860 6.706.024
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -500 17.880 -2,72 374,46 -187.228 6.695.263
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2.200 18.380 -10,69 375,00 -825.007 6.892.555
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2.451 20.580 -10,64 374,14 -917.008 7.699.725
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -200 23.031 -0,86 371,24 -74.249 8.550.144
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.501 23.231 -6,07 373,12 -560.048 8.667.874
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.400 24.732 -5,36 370,30 -518.413 9.158.136
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2.100 26.132 -7,44 369,32 -775.563 9.650.953
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.307 28.232 -4,42 368,50 -481.632 10.403.548
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -600 29.539 -1,99 366,97 -220.184 10.840.001
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.121 30.139 -3,59 366,11 -410.407 11.034.120
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15.000 31.260 92,25 175,43 2.631.450 5.483.942
2024-05-28 2024-05-23 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 17.430 104.695 19,97
2024-05-06 2024-05-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2.979 13.060 -18,57 259,12 -771.918 3.384.106
2024-05-06 2024-05-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2.181 16.039 -11,97 257,39 -561.366 4.128.270
2024-05-06 2024-05-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 5.160 18.220 39,51 119,76 617.962 2.182.027
2023-07-07 2023-07-07 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 880 13.060 7,22
2023-05-30 2023-05-25 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 33.847 87.265 63,36
2023-03-02 2023-03-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12.180 -5,43 245,10 -171.570 2.985.318
2023-03-02 2023-03-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 700 12.880 5,75 132,30 92.610 1.704.024
2023-02-02 2023-02-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12.180 -5,43 261,33 -182.931 3.182.999
2023-02-02 2023-02-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 700 12.880 5,75 132,30 92.610 1.704.024
2023-01-03 2023-01-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12.180 -5,43 276,26 -193.382 3.364.847
2023-01-03 2023-01-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X -700 12.880 -5,15 132,30 -92.610 1.704.024
2022-12-01 2022-12-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12.180 -5,43 279,89 -195.923 3.409.060
2022-12-01 2022-12-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 700 12.880 5,75 132,30 92.610 1.704.024
2022-11-02 2022-11-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12.180 -5,43 230,28 -161.196 2.804.810
2022-11-02 2022-11-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 700 12.880 5,75 132,30 92.610 1.704.024
2022-10-03 2022-10-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -710 12.180 -5,51 211,56 -150.208 2.576.801
2022-10-03 2022-10-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 710 12.890 5,83 132,30 93.933 1.705.347
2022-09-06 2022-09-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -4.910 12.180 -28,73 225,98 -1.109.550 2.752.407
2022-09-06 2022-09-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 4.910 17.090 40,31 101,80 499.838 1.739.762
2022-07-11 2022-07-08 4/A UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1.080 12.180 9,73
2022-07-08 2022-07-08 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 3.230 14.330 29,10
2022-05-31 2022-05-26 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 8.446 53.418 18,78
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise -6.310 0 -100,00
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.345 11.100 -10,81 226,74 -304.963 2.516.795
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.500 12.445 -10,76 226,04 -339.063 2.813.091
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.766 13.945 -11,24 224,38 -396.250 3.128.939
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1.699 15.711 -9,76 223,37 -379.506 3.509.366
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 6.310 17.410 56,85 76,36 481.832 1.329.428
2021-07-09 2021-07-08 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 1.080 1.080
2021-07-09 2021-07-08 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 3.230 3.230 183,98 594.255 594.255
2021-06-28 2021-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise -1.680 0 -100,00
2021-06-28 2021-06-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1.680 11.100 17,83
2021-05-24 2021-05-20 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5.027 44.972 12,58
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -15.000 0 -100,00
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -15.000 0 -100,00
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -15.000 9.420 -61,43 194,30 -2.914.500 1.830.306
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -15.000 9.420 -61,43 194,30 -2.914.500 1.830.306
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15.000 24.420 159,24 88,03 1.320.450 2.149.693
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15.000 24.420 159,24 63,90 958.500 1.560.438
2021-05-11 2021-05-10 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -10.305 0 -100,00
2021-05-11 2021-05-10 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.118 39.945 -7,24 61,62 -192.131 2.461.411
2021-05-11 2021-05-10 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 10.305 43.063 31,46 18,64 192.085 802.694
2020-09-18 2020-09-16 4 EBS Emergent BioSolutions Inc.
Common Stock
G - Gift -10.004 32.758 -23,39
2020-09-04 2020-09-02 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise 7.893 15.786 100,00
2020-09-04 2020-09-02 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -7.893 42.762 -15,58 111,23 -877.904 4.756.229
2020-09-04 2020-09-02 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 7.893 50.655 18,46 20,08 158.491 1.017.152
2020-09-04 2020-09-02 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -20.525 42.762 -32,43 111,22 -2.282.702 4.755.806
2020-06-30 2020-06-26 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 5.160 5.160
2020-06-30 2020-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 1.680 1.680
2020-06-30 2020-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise 0
2020-06-30 2020-06-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 2.300 9.420 32,30
2020-05-26 2020-05-21 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 2.821 63.287 4,67
2020-03-27 2020-03-25 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -15.000 0 -100,00
2020-03-27 2020-03-25 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -15.000 7.120 -67,81 90,54 -1.358.100 644.645
2020-03-27 2020-03-25 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15.000 22.120 210,67 48,11 721.650 1.064.193
2020-03-24 2020-03-23 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -6.000 0 -100,00
2020-03-24 2020-03-23 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -6.000 7.120 -45,73 83,95 -503.700 597.724
2020-03-24 2020-03-23 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 6.000 13.120 84,27 54,77 328.620 718.582
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -7.893 0 -100,00 13,00 -102.609
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -7.893 0 -100,00 14,71 -116.106
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -7.893 60.466 -11,55 58,96 -465.357 3.564.967
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -7.893 60.466 -11,55 58,96 -465.357 3.564.967
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 7.893 68.359 13,05 14,71 116.106 1.005.561
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 7.893 68.359 13,05 13,00 102.609 888.667
2020-01-21 2018-11-01 4/A UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -1.000 10.000 -9,09
2020-01-21 2018-11-01 4/A UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -1.000 3.370 -22,88 115,04 -115.040 387.685
2020-01-21 2018-11-01 4/A UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1.000 4.370 29,67 54,77 54.770 239.345
2019-06-28 2019-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise -3.750 0 -100,00
2019-06-28 2019-06-26 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 6.310 6.310
2019-06-28 2019-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 2.300 2.300
2019-06-28 2019-06-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 3.750 5.120 273,72
2019-05-28 2019-05-23 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5.736 60.466 10,48
2019-05-09 2019-05-07 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise -7.893 0 -100,00
2019-05-09 2019-05-07 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2.135 54.730 -3,75 49,41 -105.490 2.704.209
2019-05-09 2019-05-07 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 7.893 56.865 16,12 13,37 105.529 760.285
2019-03-04 2019-03-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1.000 8.000 -11,11
2019-03-04 2019-03-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1.000 1.370 -42,19 126,84 -126.840 173.771
2019-03-04 2019-03-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1.000 2.370 72,99 54,77 54.770 129.805
2019-02-04 2019-02-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1.000 9.000 -10,00
2019-02-04 2019-02-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1.000 1.370 -42,19 115,83 -115.830 158.687
2019-02-04 2019-02-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1.000 2.370 72,99 54,77 54.770 129.805
2019-01-03 2019-01-02 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1.000 10.000 -9,09
2019-01-03 2019-01-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1.000 1.370 -42,19 107,65 -107.650 147.480
2019-01-03 2019-01-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1.000 2.370 72,99 54,77 54.770 129.805
2018-12-04 2018-12-03 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1.000 11.000 -8,33
2018-12-04 2018-12-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1.000 1.370 -42,19 119,53 -119.530 163.756
2018-12-04 2018-12-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1.000 2.370 72,99 54,77 54.770 129.805
2018-11-02 2018-11-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X 1.000 12.000 9,09
2018-11-02 2018-11-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1.000 1.370 -42,19 115,04 -115.040 157.605
2018-11-02 2018-11-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X -1.000 2.370 -29,67 54,77 -54.770 129.805
2018-10-02 2018-10-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1.000 11.000 -8,33
2018-10-02 2018-10-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1.000 3.370 -22,88 125,96 -125.960 424.485
2018-10-02 2018-10-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1.000 4.370 29,67 54,77 54.770 239.345
2018-09-05 2018-09-04 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1.000 12.000 -7,69
2018-09-05 2018-09-04 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1.000 3.370 -22,88 119,45 -119.450 402.546
2018-09-05 2018-09-04 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1.000 4.370 29,67 54,77 54.770 239.345
2018-08-02 2018-08-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1.000 13.000 -7,14
2018-08-02 2018-08-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1.000 3.370 -22,88 116,66 -116.660 393.144
2018-08-02 2018-08-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1.000 4.370 29,67 54,77 54.770 239.345
2018-07-05 2018-07-02 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1.000 14.000 -6,67
2018-07-05 2018-07-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1.000 3.370 -22,88 113,81 -113.810 383.540
2018-07-05 2018-07-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1.000 4.370 29,67 54,77 54.770 239.345
2018-06-28 2018-06-28 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise -1.620 0 -100,00
2018-06-28 2018-06-28 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1.620 3.370 92,57
2018-06-28 2018-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 3.750 3.750
2018-06-06 2018-06-05 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -15.000 0 -100,00
2018-06-06 2018-06-05 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -15.000 1.750 -89,55 108,50 -1.627.500 189.875
2018-06-06 2018-06-05 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15.000 16.750 857,14 51,77 776.550 867.148
2018-05-24 2018-05-24 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 4.895 48.972 11,11
2017-06-30 2017-06-28 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 4.210 4.210
2017-06-30 2017-06-28 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 1.620 1.620
2017-06-22 2017-06-21 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise -1.750 0 -100,00
2017-06-22 2017-06-21 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1.750 1.750
2017-05-26 2017-05-25 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 8.259 40.077 25,96
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy) (Common Stock)
J - Other 905 10.305 9,63
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy) (Common Stock)
J - Other 693 7.893 9,62
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy) (Common Stock)
J - Other 693 7.893 9,62
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy)
J - Other 693 7.893 9,62
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy)
J - Other 693 7.893 9,62
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 577 35.818 1,64
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 604 35.241 1,74
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 152 34.637 0,44
2017-03-07 2016-06-21 4/A UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 4.910 4.910
2016-06-23 2016-06-21 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 1.750 1.750
2016-06-23 2016-06-21 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 5.000 5.000
2016-05-23 2016-05-19 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5.985 34.485 21,00
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 21.600 0 -100,00
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 21.600 0 -100,00
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 4.131 0 -100,00
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -21.600 28.500 -43,11 39,28 -848.448 1.119.480
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 21.600 50.100 75,79 11,67 252.072 584.667
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale 21.600 28.500 313,04 39,19 846.504 1.116.915
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 21.600 50.100 75,79 8,76 189.216 438.876
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -4.131 28.500 -12,66 39,00 -161.109 1.111.500
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 4.131 32.631 14,49 8,43 34.824 275.079
2016-05-16 2016-05-12 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 300 4.131 7,83
2016-05-16 2016-05-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -300 28.500 -1,04 39,00 -11.700 1.111.500
2016-05-16 2016-05-12 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 300 28.800 1,05 8,43 2.529 242.784
2016-05-13 2016-05-11 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -9.969 4.431 -69,23
2016-05-13 2016-05-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -9.969 28.500 -25,91 39,25 -391.283 1.118.625
2016-05-13 2016-05-11 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 9.969 38.469 34,98 8,43 84.039 324.294
2016-04-04 2016-03-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 124 10.811 1,16
2016-03-14 2016-03-11 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -14.879 0 -100,00
2016-03-14 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -14.879 28.500 -34,30 34,03 -506.332 969.855
2016-03-14 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 14.879 43.379 52,21 10,28 152.956 445.936
2016-03-14 2016-03-10 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -14.820 14.879 -49,90
2016-03-14 2016-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -14.820 28.500 -34,21 35,34 -523.739 1.007.190
2016-03-14 2016-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 14.820 43.320 52,00 10,28 152.350 445.330
2016-03-07 2016-03-04 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 1.103 14.096 8,49
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Stock Option (right-to-buy)
M - Exercise -7.898 0 -100,00
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -7.898 12.993 -37,81 168,63 -1.331.840 2.191.010
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 7.898 20.891 60,79 59,89 473.011 1.251.162
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -3.837 12.993 -22,80 168,50 -646.534 2.189.320
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
F - Taxes -633 16.830 -3,62 168,93 -106.933 2.843.092
2016-01-21 2015-06-30 4/A HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 137 10.466 1,33
2016-01-04 2015-12-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 101 10.684 0,95
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Stock Option Right to Buy
M - Exercise -7.540 0 -100,00
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Stock Option Right to Buy
M - Exercise -6.137 0 -100,00
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -704 17.463 -3,88 154,48 -108.754 2.697.684
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -1.241 18.167 -6,39 153,89 -190.977 2.795.720
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -2.300 19.408 -10,60 154,57 -355.511 2.999.895
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -5.240 21.708 -19,44 153,94 -806.646 3.341.730
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 7.540 26.948 38,85 51,23 386.274 1.380.546
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -1.700 19.408 -8,05 154,58 -262.786 3.000.089
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -4.437 21.108 -17,37 153,95 -683.076 3.249.577
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 6.137 25.545 31,62 47,31 290.341 1.208.534
2015-10-01 2015-09-30 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 135 10.600 1,29
2015-09-29 2015-06-26 4/A UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 15.000 15.000
2015-07-02 2015-06-30 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 126 10.455 1,22
2015-06-29 2015-06-26 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 15.000 15.000
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise -15.000 15.000 -50,00
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -30.000 0 -100,00
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -15.000 0 -100,00 185,60 -2.783.973
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15.000 15.000 30,75 461.250 461.250
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -30.000 0 -100,00 185,78 -5.573.400
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 30.000 30.000 41,14 1.234.200 1.234.200
2015-06-17 2015-06-16 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -13.457 29.699 -31,18
2015-06-17 2015-06-16 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -13.457 28.500 -32,07 31,32 -421.541 892.762
2015-06-17 2015-06-16 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 13.457 41.957 47,22 10,28 138.338 431.318
2015-05-21 2015-05-21 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 9.400 28.500 49,21
2015-04-01 2015-03-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 118 10.331 1,16
2015-03-31 2015-03-27 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
F - Taxes -390 19.408 -1,97 138,80 -54.132 2.693.830
2015-03-10 2015-03-09 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
F - Taxes -667 19.798 -3,26 138,97 -92.693 2.751.328
2015-03-04 2015-03-03 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 1.317 20.465 6,88
2015-01-05 2014-12-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 118 10.214 1,17
2014-10-01 2014-09-30 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 155 10.110 1,56
2014-09-02 2014-08-29 4 HSIC HENRY SCHEIN INC
Stock Option (Right to Buy)
M - Exercise -13.862 0 -100,00
2014-09-02 2014-08-29 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -3.400 19.148 -15,08 120,32 -409.088 2.303.887
2014-09-02 2014-08-29 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -13.862 22.548 -38,07 119,91 -1.662.192 2.703.731
2014-09-02 2014-08-29 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 13.862 36.410 61,48 39,43 546.579 1.435.646
2014-07-02 2014-06-30 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 181 9.954 1,85
2014-06-27 2014-06-26 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
A - Award 15.000 15.000
2014-05-23 2014-05-22 4 EBS Emergent BioSolutions Inc.
Director Stock Option (right to buy)
A - Award 9.400 9.400
2014-05-23 2014-05-22 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 4.700 19.100 32,64
2014-05-23 2014-05-22 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise X -30.000 0 -100,00
2014-05-23 2014-05-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -4.900 0 -100,00 101,02 -494.983
2014-05-23 2014-05-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -25.100 4.900 -83,67 101,55 -2.548.845 497.583
2014-05-23 2014-05-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 30.000 30.000 31,17 935.100 935.100
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Stock Option (Right to Buy)
M - Exercise -500 6.137 -7,53
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Stock Option (Right to Buy)
M - Exercise -1.138 13.862 -7,59
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -500 22.548 -2,17 115,95 -57.975 2.614.441
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 500 23.048 2,22 47,31 23.655 1.090.401
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -1.138 22.548 -4,80 116,04 -132.054 2.616.470
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 1.138 23.686 5,05 39,43 44.871 933.939
2014-04-02 2014-03-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 134 9.816 1,38
2014-03-03 2014-02-27 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 9.638 9.638
2014-03-03 2014-02-27 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 1.561 22.548 7,44
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise -30.000 0 -100,00
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise -12.000 0 -100,00
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -42.000 0 -100,00 78,48 -3.296.122
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 30.000 42.000 250,00 27,70 831.000 1.163.400
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 12.000 12.000 24,39 292.680 292.680
2013-08-21 2013-08-20 4 HSIC HENRY SCHEIN INC
Stock Option (Right to Buy)
M - Exercise -15.000 0 -100,00
2013-08-21 2013-08-20 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -15.000 20.987 -41,68 103,91 -1.558.650 2.180.759
2013-08-21 2013-08-20 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 15.000 35.987 71,47 35,49 532.350 1.277.179
2013-06-27 2013-06-26 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
A - Award 15.000 15.000
2013-05-24 2013-05-23 4 EBS Emergent BioSolutions Inc.
Director stock option (right to buy)
A - Award 7.200 7.200
2013-05-24 2013-05-23 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 3.600 14.400 33,33
2013-03-12 2013-03-08 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
F - Taxes -1.346 20.987 -6,03 90,32 -121.571 1.895.546
2013-03-04 2013-03-01 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 2.086 22.333 10,30 88,84 185.320 1.984.064
2012-06-27 2012-06-26 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
A - Award 15.000 15.000
2012-05-21 2012-05-17 4 EBS Emergent BioSolutions Inc.
Director Stock Option (Right to buy)
A - Award 7.200 7.200
2012-05-21 2012-05-17 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 3.600 10.800 50,00
2012-03-30 2012-03-30 4 BPAX BIOSANTE PHARMACEUTICALS INC
Non-Statutory Stock Option (right to buy)
A - Award 10.000 10.000
2012-03-30 2012-03-30 4 BPAX BIOSANTE PHARMACEUTICALS INC
Non-Statutory Stock Option (right to buy)
A - Award 25.000 25.000
2012-03-06 2012-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 2.536 20.248 14,32 73,12 185.432 1.480.534
2011-01-03 2011-01-03 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise X -6.000 24.000 -20,00
2011-01-03 2011-01-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -6.000 0 -100,00 63,93 -383.591
2011-01-03 2011-01-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 6.000 6.000 24,39 146.340 146.340
2004-04-30 2004-04-28 4 EFX EQUIFAX INC
Stock Option/Right to Buy
A - Award 7.000 7.000 24,68 172.760 172.760
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)